Cart
sales@molnova.com
Dihydronarwedine
CAS No. 21041-10-1
Dihydronarwedine( ——— )
Catalog No. M39419 CAS No. 21041-10-1
Dihydronarwedine (Lycoraminone) is the alkaloid. Dihydronarwedine inhibits 39% activity of glycogen synthase kinase-3β (GSK-3β) at a concentration of 10 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 869 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydronarwedine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydronarwedine (Lycoraminone) is the alkaloid. Dihydronarwedine inhibits 39% activity of glycogen synthase kinase-3β (GSK-3β) at a concentration of 10 μM.
-
DescriptionDihydronarwedine (Lycoraminone) is the alkaloid. Dihydronarwedine inhibits 39% activity of glycogen synthase kinase-3β (GSK-3β) at a concentration of 10 μM.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorGSK-3β
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number21041-10-1
-
Formula Weight287.35
-
Molecular FormulaC17H21NO3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hulcová D, et al., Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer's disease. Phytochemistry. 2019 Sep;165:112055.?
molnova catalog
related products
-
Pixantrone dimaleate
Pixantrone dimaleate (BBR 2778 dimaleate) is an experimental antineoplastic drug.
-
PLM derived peptide
PLM derived peptide
-
IFN-γ Antagonist
IFN-γ Antagonist
